Handa Pharmaceuticals (ROCO:6620) COGS-to-Revenue : 0.00 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Handa Pharmaceuticals COGS-to-Revenue?

Handa Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2024 was NT$0.0 Mil. Its Revenue for the three months ended in Dec. 2024 was NT$0.0 Mil.

Handa Pharmaceuticals's COGS to Revenue for the three months ended in Dec. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Handa Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2024 was N/A%.

Handa Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Handa Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handa Pharmaceuticals COGS-to-Revenue Chart

Handa Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.05

0.09

Handa Pharmaceuticals Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Handa Pharmaceuticals COGS-to-Revenue Calculation

Handa Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.172	/	830.674
	=	0.00

Handa Pharmaceuticals's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Handa Pharmaceuticals (ROCO:6620) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Handa Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Handa Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Handa Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Handa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handa Pharmaceuticals Inc (ROCO:6620) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nanke 3rd Road, 3F-1,3F-2, No.23, Xinshi Dist, Tainan, TWN, 74147

Website

https://www.handapharma.com.tw

Handa Pharmaceuticals Inc is a Taiwan-based specialty pharmaceutical company. It is engaged in the development of niche drugs. The company focuses on the development of high-barrier/patentable niche products.

Handa Pharmaceuticals Headlines

No Headlines